jnc for hypertension

Release time :Nov-25,2024

The Joint National Committee (JNC) Guidelines on the prevention and treatment of hypertension serve as a pivotal reference for diagnosing, assessing, and managing high blood pressure. Hypertension is categorized as having a systolic blood pressure of 140 mmHg or higher and/or a diastolic blood pressure of 90 mmHg or higher in adults not on antihypertensive medications, based on consistent measurements taken on separate occasions.

The JNC guidelines advocate for a multifaceted approach to hypertension management. Initially, for patients newly diagnosed with hypertension, lifestyle modifications are the first line of treatment. This encompasses weight reduction, increased physical activity, sodium restriction, potassium supplementation, alcohol reduction, and smoking cessation. Subsequently, for individuals whose blood pressure remains above target levels, the JNC recommends initiating antihypertensive pharmacotherapy. The commonly prescribed medications include angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers, and diuretics. The selection of antihypertensive drugs should be tailored to the patient's age, gender, ethnicity, and comorbidities.

Lastly, for individuals with hypertension, beyond pharmacological interventions, regular blood pressure monitoring, lifestyle adjustments, and management of comorbidities are essential. Patients are advised to adhere to their physician's instructions, take medications as prescribed, and avoid stopping or changing medications without consultation. Should any concerns or discomforts arise, prompt medical advice should be sought.